Native Valve Endocarditis due to Candida glabrata Treated without Valvular Replacement: A Potential Role for Caspofungin in the Induction and Maintenance Treatment

Conventional antifungal therapy for fungal endocarditis has been associated with a poor cure rate. Therefore, combined medical and surgical therapy has been recommended. However, new potent antifungal agents, such as echinocandins, could increase the medical options and, in some cases, avoid the nee...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical infectious diseases 2004-10, Vol.39 (7), p.e70-e73
Hauptverfasser:	Jiménez-Expósito, M. J., Torres, G., Baraldés, A., Benito, N., Marco, F., Paré, J. C., Moreno, A., Claramonte, X., Mestres, C. A., Almela, M., García de la María, C., Pérez, N., Schell, W. A., Corey, G. R., Perfect, J., Jiménez de Anta, M. T., Gatell, J. M., Miró, J. M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged, 80 and over Amphotericin B - therapeutic use Antifungal Agents - therapeutic use Candida glabrata Candidiasis - diagnosis Candidiasis - microbiology Drug Therapy, Combination Echinocandins Endocarditis - drug therapy Endocarditis - microbiology Female Humans Lipopeptides Peptides, Cyclic - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!